Foreign clinical trials need stricter controls, HHS study says

July 20, 2010

More than half of clinical trial subjects and sites for drugs and biologics were located outside the United States in fiscal 2008, a new study said. And 80% of the drug and biologic marketing applications that the Food and Drug Administration approved contained foreign clinical trial data. (American Medical News)